Partizanske

Slovakia

12 total trials 3 recruiting

Filter these 12 trials by phase, condition, sponsor and more.

Open in Search →

A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have … Recruiting

2025-521730-28-00 4 2026-03-30 Colorectal Cancer with Cancer Cachexia
A study to compare pharmacokinetics, efficacy, safety, and immunogenicity of MB12 (proposed pembrolizumab biosimilar) to Keytruda® in non-sm … Recruiting

2024-515853-48-00 5 2025-09-05 advanced/metastatic non-squamous non-small cell lung cancer (NSCLC)
Phase 3, Open-label Study of ARV-471 (PF-07850327) vs Fulvestrant in Participants With ER(+)/ HER2(-) Advanced Breast Cancer (VERITAC-2) Recruiting

2022-500544-38-00 5 2023-06-05 Advanced Breast Cancer
Phase 3, Randomized, Open-Label Study of ARV-471 (PF-07850327) Plus Palbociclib vs Letrozole Plus Palbociclib in Participants With ER(+)/HER … Ended recruitment

2022-500545-24-00 5 2023-10-04 ER + /HER 2 - Advanced Breast Cancer
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable … Ended recruitment

2023-504195-14-00 5 2022-08-31 PD-L1-negative metastatic triple-negative breast cancer or PD-L1-posit
Three-arm study of the clinical efficacy, safety and tolerability of ianalumab (VAY736) in patients with active Sjögren’s syndrome Ended recruitment

2024-511068-10-00 5 2022-08-04 Sjögren’s Syndrome
A randomized, double-blind, Phase III Study of AZD9833 plus CDK4/6 inhibitor in patients with metastatic breast cancer with detectable ESR1 … Ended recruitment

2023-503990-39-00 5 2021-09-30 Estrogen Receptor-Positive, HER-2 negative Advanced Breast Cancer
A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC. Ended

2024-510640-32-00 5 2024-10-16 Stage IV Non-squamous non-small cell lung cancer
A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered i … Ended

2023-506696-10-00 5 2024-06-18 Non-Small Cell Lung Cancer
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENT … Ended

2023-510446-24-00 4 2023-05-30 Cancer cachexia
Phase 2 Study of Encorafenib and Binimetinib Plus Pembrolizumab in Participants With BRAF V600E/K Mutation-Positive Melanoma Who Progressed … Ended

2023-509471-17-00 4 2023-05-24 Metastatic or unresectable locally advanced BRAF V600E/K mutation posi
Phase 3b/4 Study in Rheumatoid Arthritis Ended

2023-508022-10-00 6 2019-07-25 Rheumatoid Arthritis

Showing 1–12 of 12 trials